Recombinant adenoviruses for gene therapy in cancers
USRE39078E1 · kind E1 · reissue
0Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 1994 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | Nov 7, 2014 |
Classification
- Technology area (CPC —)General
Abstract
The invention concerns recombinant viruses comprising a heterologous DNA sequence under the control of expression signals specifically active in tumor cells, and their preparation and use in the treatment and prevention of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.